NCT05256069View on ClinicalTrials.gov

Sex-related Differences in Sympathetic Vascular Transduction in the Setting of Hypoxemia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 26, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
VasodilationHypoxia
Interventions
DRUG

Propranolol Pill

Participants will receive a β-blockade (propranolol pill, 1 mg/kg dosed based on participant weight).

DRUG

Placebo

Participants will receive a placebo in pill form.

Trial Locations (1)

65211

University of Missouri-Columbia, Columbia

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

University of Missouri-Columbia

OTHER